ECSP034536A - DERIVATIVES OF PROPIONIC ACID - Google Patents

DERIVATIVES OF PROPIONIC ACID

Info

Publication number
ECSP034536A
ECSP034536A EC2003004536A ECSP034536A ECSP034536A EC SP034536 A ECSP034536 A EC SP034536A EC 2003004536 A EC2003004536 A EC 2003004536A EC SP034536 A ECSP034536 A EC SP034536A EC SP034536 A ECSP034536 A EC SP034536A
Authority
EC
Ecuador
Prior art keywords
derivatives
propionic acid
ppar
variables
graph
Prior art date
Application number
EC2003004536A
Other languages
Spanish (es)
Inventor
Klaus Urbahns
Susanne Nikolic
Joseph Pernerstorfer
Wengenroth Elke Dittrich
Dietrich Claudia Hirth
Klemens Lustig
Berthold Hinzen
Michael Woltering
Hilmar Bjschoff
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of ECSP034536A publication Critical patent/ECSP034536A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/12—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/18—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C317/28—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to acyclic carbon atoms of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/52—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La presente solicitud se refiere a compuestos activadores de ppar-alfa de formula general para el tratamiento de por ejemplo la enfermedad coronaria así como a su preparación teniendo las variables R1,R2,R3,R4,R5,R6,R7,R8,R9,R10,R11,R12,R13, A y X los significados indicados en la reivindicación 1. (gráfico).The present application refers to ppar-alpha activating compounds of general formula for the treatment of for example coronary heart disease as well as its preparation having the variables R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12, R13, A and X the meanings indicated in claim 1. (graph).

EC2003004536A 2000-10-05 2003-04-03 DERIVATIVES OF PROPIONIC ACID ECSP034536A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10049208 2000-10-05

Publications (1)

Publication Number Publication Date
ECSP034536A true ECSP034536A (en) 2003-05-26

Family

ID=7658699

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2003004536A ECSP034536A (en) 2000-10-05 2003-04-03 DERIVATIVES OF PROPIONIC ACID

Country Status (9)

Country Link
KR (1) KR20030059175A (en)
AR (1) AR035203A1 (en)
DE (1) DE10124905A1 (en)
DO (1) DOP2001000260A (en)
EC (1) ECSP034536A (en)
GT (1) GT200100198A (en)
PE (1) PE20020475A1 (en)
SV (1) SV2002000677A (en)
ZA (1) ZA200302610B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004247355A1 (en) 2003-06-06 2004-12-23 F. Hoffmann-La Roche Ag Aniline derivatives
KR100699928B1 (en) 2004-10-05 2007-03-26 재단법인서울대학교산학협력재단 Method for preparing intermediates for the preparation of peroxysomal proliferator activated receptor alpha ligands

Also Published As

Publication number Publication date
DOP2001000260A (en) 2002-12-15
GT200100198A (en) 2002-06-25
DE10124905A1 (en) 2002-04-11
PE20020475A1 (en) 2002-06-08
SV2002000677A (en) 2002-12-02
AR035203A1 (en) 2004-05-05
KR20030059175A (en) 2003-07-07
ZA200302610B (en) 2004-04-05

Similar Documents

Publication Publication Date Title
UY26332A1 (en) NEW DERIVATIVES OF AMINODICARBOXYLIC ACID WITH PHARMACEUTICAL PROPERTIES.
CY1107807T1 (en) Pyrimidine derivatives
UY27878A1 (en) INDOLINFENYL SULFONAMIDE DERIVATIVES
TR200100410T2 (en) 2- (purin-9-yl) -tetrahydrofuran-3,4-diol derivatives.
ATE253586T1 (en) 2-(PURIN-9-YL)-TETRAHYDROFURAN-3,4-DIOL DERIVATIVE
PA8432901A1 (en) PIRIDILPIRROL COMPOUNDS
AP2000001881A0 (en) 2-(Purine-9-YL)-tetrahydrofuran-3,4 4-diol derivatives.
AR022469A1 (en) USE OF SUBSTITUTED AND DERIVATIVE ISOXAZOLCARBOXILIC ACIDS AND NEW SUBSTANCES
ATE268179T1 (en) USE OF SUBSTITUTED IMIDAZO (1,2-A)PYRIDINE, PYRIMIDINE AND PYRAZINE-3-YL-AMINE DERIVATIVES FOR THE PRODUCTION OF NOS INHIBITION MEDICATIONS
ES2061452T3 (en) NEW HETRAZEPINES AND PROCEDURE FOR THE PREPARATION.
AR036114A1 (en) TETRAHYDROIMIDAZOL [1,2-A] PIRAZINS AND TETRAHYDROTRIAZOL [4,3-A] PIRAZINS AS INHIBITORS OF DIPEPTIDIL PEPTIDASE USEFUL FOR THE TREATMENT OR PREVENTION OF DIABETES
UY26256A1 (en) CARBOXYLIC ACID AMIDES, MEDICINES CONTAINING THESE COMPOUNDS, THEIR USE AND THEIR PREPARATION
BG104729A (en) 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
ES2013067A6 (en) Piperazine derivative or its salt, process for producing the same and pharmaceutical composition comprising the same as active ingredient
DK0430045T3 (en) Ascorbic acid ethocopheryl phosphate diesters to inhibit Maillard's reaction
MX9201598A (en) BENZO PIRANONA, PROCEDURE FOR ITS PREPARATION AND USE.
DE60110415D1 (en) Novel pyrazine derivatives or salts thereof, pharmaceutical compositions containing the derivatives or their salts, and intermediates for the preparation of the derivatives
ES2098790T3 (en) DERIVATIVES OF 1,2,3,5,6,7,8,8A-OCTAHIDRO-5,5,8A-TRIMETIL- (8ABETA) -6-ISOQUINOLEINAMINA, ITS PREPARATION PROCEDURE AND ITS USE IN THERAPEUTICS.
MX9503529A (en) Glycinamide derivatives, process for their preparation and medicaments containing them.
BR0111358A (en) Thioacetamide compounds and their use
AR028914A1 (en) 2-GUANIDINO-4-ARIL-QUINAZOLINAS AS NHE-3 INHIBITORS
ECSP045469A (en) THE USE OF REPLACED CYANOPIRROLIDINS AND COMBINATION PREPARATIONS CONTAINING THEM TO TREAT HYPERLIPIDEMIA AND ASSOCIATED DISEASES
UY26951A1 (en) DERIVATIVES OF OWN ACID
DOP2002000481A (en) ACETIC ACID DERIVATIVES
AR024380A1 (en) TIENOPIRIMIDINES